Drug recall · March 14, 2018
Atropine Sulfate Ophthalmic 1% Solution recall
Why: Failed Stability Specification: OOS low viscosity results discovered during retain testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-215-05
- Lots / codes
Lot: 011037A
- Quantity
- 31,812 bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide in the USA
- Initiated
- February 21, 2018 · Voluntary: Firm initiated
- Classified
- March 5, 2018
- Reported
- March 14, 2018
- Ended
- August 31, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.